You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Does Maternal Obesity Affect Childhood Cancer?

  • Authors: News Author: Roxanne Nelson, RN, BSN; CME Author: Laurie Barclay, MD
  • CME / CE Released: 8/16/2019
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/16/2020
Start Activity


Target Audience and Goal Statement

This article is intended for primary care physicians, obstetricians/gynecologists/women's health practitioners, hematologists/oncologists, nurses, and other members of the healthcare team for pregnant women and their offspring.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will:

  • Describe the association of maternal anthropometric characteristics derived from birth certificates with an increased risk for development of cancer in childhood after adjustment for known maternal and infant risk factors, according to a registry study
  • Identify clinical implications of the association of maternal anthropometric characteristics with an increased risk for development of cancer in childhood, according to a registry study


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


News Author

  • Roxanne Nelson, RN, BSN

    Journalist, Medscape Oncology

    Disclosures

    Disclosure: Roxanne Nelson, RN, BSN, has disclosed no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer, Medscape, LLC

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor/CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Nurse Planner

  • Hazel A. Dennison, DNP, RN, FNP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel A. Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Does Maternal Obesity Affect Childhood Cancer?

Authors: News Author: Roxanne Nelson, RN, BSN; CME Author: Laurie Barclay, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 8/16/2019

Valid for credit through: 8/16/2020

processing....

Clinical Context

Although childhood cancer is relatively rare, it is still the leading cause of death past infancy among children in the United States. Infants and children are especially susceptible to prenatal and early-life exposures. Maternal exposures before and during pregnancy (eg, obesity) could therefore have a significant effect on the health of the child, including a risk for cancer development.

The goal of this registry study by Stacy and colleagues was to evaluate the association of maternal anthropometric characteristics derived from birth certificates with an increased risk for development of cancer in childhood after adjustment for known maternal and infant risk factors.

Study Synopsis and Perspective

Obesity has been linked to an increased risk for cancer in adults, but its potential role in childhood cancers is less clear. New findings suggest that infants born to obese mothers are more likely to develop cancer in early childhood.

An analysis of data from almost 2 million infants found that the offspring of women who were severely obese (body mass index [BMI] >40 kg/m2) were twice as likely to develop leukemia before age 5 years than the offspring of women who were of normal weight.

After adjusting for confounders such as maternal age and race, which are 2 established risk factors for childhood cancer, maternal obesity was associated with the risk for childhood cancer.

"Right now, we don't know of many avoidable risk factors for childhood cancer," said lead author Shaina Stacy, PhD, postdoctoral scholar in the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania.

"My hope is that this study can be, in a way, empowering and also motivating for weight loss," she said in a statement.

The study was published online in the American Journal of Epidemiology.

High BMI Linked to Cancer Risk

For the study, Dr Stacy and colleagues used data from the Pennsylvania Department of Health. They identified 1,827,875 infants who were born between 2003 and 2015.

A total of 2352 children were diagnosed with any type of cancer, and 747 children were diagnosed with leukemia before age 14 years.

The most common diagnoses were acute lymphoblastic leukemia (ALL) and neuroblastoma.

Older maternal age was associated with a higher risk for any childhood cancer, including leukemia. Nonwhite race was associated with a lower risk. The analyses were adjusted for these risk factors.

The offspring of women with a BMI ≥40 kg/m2 had a 1.32 times higher risk of developing any type of cancer and 1.57 times higher risk for leukemia compared with children born to mothers with BMIs of 18.5 to 24.9 kg/m2.

In addition, children born to mothers with prepregnancy weights of 90 to 99 kg and ≥100 kg had a 46% and 42% higher risk for leukemia, respectively.

With respect to infant factors, the authors found that those infants whose birth weight was 30% lower than expected or 30% higher than expected had a 37% and a 116% higher risk for any childhood cancer, respectively, as compared with infants who were within 10% of their expected weight (P curvilinearity <.0001).

Infants whose birth weight was ≥30% higher than expected had an 84% higher risk of developing leukemia. Infants who were large for gestational age also had a greater risk for any cancer and leukemia in comparison with infants who were of appropriate size.

"We are dealing with an obesity epidemic in this country," said senior author Jian-Min Yuan, MD, PhD, professor of epidemiology at University of Pittsburgh Public Health and coleader of the Cancer Epidemiology and Prevention Program at UPMC Hillman Cancer Center, in a statement.

"From a prevention point of view, maintaining a healthy weight is not only good for the mother but also for the children, too," he said.

Weighing in on the study, Maria Chang Swartz, PhD, MPH, RD, LD, assistant professor, department of pediatrics-research, The University of Texas MD Anderson Cancer Center, Houston, Texas, noted that, overall, the findings from this study point to an area that needs further investigation.

"I agree that at this time, the biological mechanisms are still unknown," she said. "The authors' conjecture regarding the role of insulin-like growth hormone factor is an area that is receiving a lot of attention, especially given that stronger evidence is showing an association between high prepregnancy BMI and risk for childhood obesity."

Nonetheless, she did not feel there is enough evidence at this time to include a discussion of a risk for childhood leukemia during the prepregnancy consults for women with high BMIs, "[b]ut maintaining a healthy weight is important, because obesity is associated with many health issues," Dr Swartz said. "Given that stronger evidence is showing an association between high prepregnancy BMI and risk for gestational diabetes as well as risk for childhood obesity in their offspring, there is a need to emphasize maintenance of healthy weight among women of childbearing age," she said.

The study was partially supported by the Arnold Palmer Endowment Fund. Stacy was supported by the National Cancer Institute of the National Institutes of Health. The other authors have disclosed no relevant financial relationships.

Am J Epidemiol. Published online May 20, 2019.[1]

Study Highlights

  • The Pennsylvania State Department of Health linked birth and cancer registry files, yielding a virtual cohort of births and childhood cancers from 2003 through 2016, including 1,827,875 infants and 13,785,309 person-years at risk.
  • 2352 children were diagnosed with any cancer and 747 with leukemia before age 14 years.
  • Risk for leukemia, specifically ALL, before the age of 5 years was 57% higher in children born to mothers with BMI ≥40 (95% CI: 12, 120) kg/m2 than in children born to normal-weight mothers after adjustment for maternal age and race.
  • Beginning at a maternal BMI of 30 kg/m2, there was a suggestive dose-response relationship with increasing BMI.
  • The risk for leukemia was 46% higher in children born to mothers with prepregnancy weights of 90-99 kg and 42% higher in mothers with prepregnancy weights ≥100 kg.
  • High birth weight, newborn size, and preterm birth were all associated with an increased risk for any childhood cancer.
  • Compared with newborns of expected size, newborns sized ≥30% higher than expected had 2.2-fold hazard ratios (HR) for total childhood cancer and 1.8-fold HR for leukemia.
  • Newborn size 30% below expected was also associated with an increased overall cancer risk (P curvilinearity <.0001).
  • The association between maternal obesity and childhood cancer was not mediated by newborn size.
  • Maternal weight gain during pregnancy was associated with a higher risk for neuroblastoma in the offspring (HR=2.07 [95% CI: 1.06, 4.04]) for weight gain ≥30 kg compared with <5 kg.
  • Nonetheless, there were few neuroblastoma cases, warranting additional studies to confirm this observation.
  • According to their findings, the investigators concluded that early-life exposure to maternal obesity- and fetal growth-related factors plays a significant role in childhood cancer development.
  • Overall, the results are consistent with most previous studies, but this study showed a novel association between maternal prepregnancy obesity and a risk for any childhood cancer, leukemia, and ALL, which was not mediated by newborn size.
  • In addition, this study showed a U-shaped relationship between relative birth size and childhood cancer risk.
  • If the findings are confirmed by studies in other populations, it would provide a rationale for weight control among women planning to conceive as a possible preventive measure against cancer risk in their children.
  • Regardless of the potential risk for cancer in the offspring, women of childbearing age should maintain a healthy weight because obesity is associated with many health problems, including gestational diabetes and a risk for childhood obesity in the offspring.
  • The investigators recommended future studies to clarify the biological mechanisms underlying the association of early-life exposure through maternal obesity or large or small infant size with a risk for development of childhood cancer.
  • Such mechanisms are currently unknown but may be related to changes in hormones and inflammatory markers associated with the insulin-like growth factor axis.
  • Obesity can trigger disruptions to normal circulating levels of insulin and insulin-like growth factors, which are known risk factors for certain cancers in adults.
  • Maternal obesity may also affect childhood cancer risk through epigenomic modifications, as is suggested in animal models.
  • Cell proliferation favoring larger newborn size may also favor tumorigenesis, with insulin-like growth factors possibly associated with childhood cancer development because of the increased number of cells at risk for genetic damage in larger infants.
  • Study limitations include reliance on linkage analysis with the Pennsylvania state cancer registry for identification of childhood cancer and use of BMI as a marker for adiposity.
  • Future studies should also use other measures of maternal adiposity in addition to BMI.

Clinical Implications

  • Prenatal exposure to maternal obesity- and fetal growth–related factors appears to increase the risk for development of childhood leukemia and other cancer, according to a registry study by Stacy and colleagues.
  • If the findings are confirmed by studies in other populations, it would provide a rationale for weight control among women planning to conceive as a possible preventive measure against cancer risk in their children.
  • Implications for the Healthcare Team: Regardless of the potential risk for cancer in the offspring, women of childbearing age should maintain a healthy weight because obesity is associated with many health problems, including gestational diabetes and a risk for childhood obesity in the offspring.

 

Earn Credit

  • Print